CHICAGO--(BUSINESS WIRE)--BioGX, a global provider of easy molecular diagnostic solutions, announced the launch of a point-of-care (POC) CE-Marked, three gene multiplex COVID-19 test on its pixl ...

PCR processes are the diagnostic gold standard when it comes to identifying coronavirus infections. Unlike rapid antigen tests, they function even in the case of a low viral load and detect the ...

New York, NY—July 25, 2022—For more than 30 years, polymerase chain reaction (PCR) has been the gold standard in molecular diagnostic testing, detecting genetic material, such as those from a virus or ...

This blog was written by Simran Goyal, a fourth year medical student at the University of Cambridge. Simran was on placement for her Student Selected Component (SSC) with us between 10 December 2018 ...

Visby Medical Inc. secured $12.3 million in funding from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to develop a next generation device to detect influenza and COVID-19 in ...

For more than 30 years, polymerase chain reaction (PCR) has been the gold standard in molecular diagnostic testing, detecting genetic material, such as those from a virus or from human DNA. But PCR, ...

Researchers have built an RT-PCR platform that gives results in 23 minutes that match the longer laboratory-based tests -- faster than other PCR tests on the market. It can be adapted to test for a ...